These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12783762)

  • 1. [Adverse reactions to vaccines].
    Eseverri JL; Ranea S; Marin A
    Allergol Immunopathol (Madr); 2003; 31(3):125-38. PubMed ID: 12783762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids.
    Nakayama T; Aizawa C; Kuno-Sakai H
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):321-5. PubMed ID: 9949325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J; Casey CG; Bell DM;
    MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine.
    Stratton KR; Howe CJ; Johnston RB
    JAMA; 1994 May; 271(20):1602-5. PubMed ID: 8182813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States.
    Pool V; Braun MM; Kelso JM; Mootrey G; Chen RT; Yunginger JW; Jacobson RM; Gargiullo PM;
    Pediatrics; 2002 Dec; 110(6):e71. PubMed ID: 12456938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine allergy and pseudo-allergy.
    Ponvert C; Scheinmann P
    Eur J Dermatol; 2003; 13(1):10-5. PubMed ID: 12609774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic reactions to measles-mumps-rubella vaccination.
    Patja A; Mäkinen-Kiljunen S; Davidkin I; Paunio M; Peltola H
    Pediatrics; 2001 Feb; 107(2):E27. PubMed ID: 11158501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Needle size for vaccination procedures in children and adolescents.
    Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermal testing of vaccines for children at high risk of allergies.
    Sugai K; Shiga A; Okada K; Iwata T; Ogura H; Maekawa K; Yokota S
    Vaccine; 2007 Apr; 25(17):3454-63. PubMed ID: 17276555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous immunization with B.C.G., diphtheria-tetanus, and oral poliomyelitis vaccines in children aged 13-14.
    Galbraith NS; Crosby G; Barnes JM; Fernandes R
    Br Med J; 1971 Apr; 2(5755):193-7. PubMed ID: 5575951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasible improvements in vaccines in the Expanded Programme on Immunization.
    McIntosh K
    Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization to bovine serum albumin as a possible cause of allergic reactions to vaccines.
    de Silva R; Dasanayake WMDK; Wickramasinhe GD; Karunatilake C; Weerasinghe N; Gunasekera P; Malavige GN
    Vaccine; 2017 Mar; 35(11):1494-1500. PubMed ID: 28216185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological adverse events associated with vaccination.
    Piyasirisilp S; Hemachudha T
    Curr Opin Neurol; 2002 Jun; 15(3):333-8. PubMed ID: 12045734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergenic components of vaccines and avoidance of vaccination-related adverse events.
    Georgitis JW; Fasano MB
    Curr Allergy Rep; 2001 Jan; 1(1):11-7. PubMed ID: 11899279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids.
    Relyveld EH; Bizzini B; Gupta RK
    Vaccine; 1998; 16(9-10):1016-23. PubMed ID: 9682353
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.